Will xarelto be generic in 2026?

Short answer: It’s not guaranteed. Whether a generic rivaroxaban (Xarelto) will be available in 2026 depends on patent protections, any ongoing patent litigation or settlements, and regulatory approvals. If patents and related protections expire or are cleared for generic use by then, a generic could enter the market; if not, Xarelto may remain the brand-name option longer.

Things that influence the timeline:
- Patent expirations and any legal challenges to those patents
- Settlements between the brand sponsor and generic manufacturers
- FDA approval of generic rivaroxaban formulations
- Market factors like manufacturing capacity and payer pricing

If you want, tell me your country (US, EU, Canada, etc.). I can outline the current status there and how to check up-to-date information (e.g., FDA Orange Book entries, USPTO patent status, or local regulatory announcements). Also I can help you compare costs between Xarelto and potential generics once they’re available in your area.